Paper

Intra-articular polyacrylamide hydrogel for the treatment of 20 horses with non-responsive osteoarthritis of the interphalangeal joints.

Bathe, A.P., Read, R., Briggs, C.

Abstract

Bathe, A.P., Read, R., Briggs, C., Intra-articular polyacrylamide hydrogel for the treatment of 20 horses with non-responsive osteoarthritis of the interphalangeal joints: a prospective study [abstract]. Veterinary Orthopaedic Society 43rd Annual Conference, USA. 2016; 4-5.

Introduction: Polyacrylamide hydrogel (PAAG) is a novel treatment for osteoarthritis (OA), but many previous case series have poorly defined clinical inclusion criteria. The aim of this study was to determine the efficacy of PAAG in equine arthritic interphalangeal joints, which had not responded to previous intra-articular treatment with corticosteroids.

Materials and Methods: Lameness was localized to the proximal/distal inter-phalangeal joint by diagnostic analgesia; radiography/standing MRI was consistent with OA. After treatment with 1ml of PAAG (Arthramid Vet, Contura International) intra-articularly horses had 4 weeks of exercise restriction be-fore a progressive return to ridden exercise. Follow-up was by re-examination and telephone survey.

Results: 20 horses met the inclusion criteria. All were adult sport horses with persistent lameness after previous treatment with corticosteroids. The average lameness duration was 15mo and average lameness score was 3/10. 10 had arthritic changes evident radiologically. 18 underwent MRI examination and all had osteoarthritic changes. One horse was treated twice and had a transient adverse reaction. Long term follow-up was available on 18 cases; with median follow-up of 12mo. 12/18 returned to full function; 3/18 to lower level and 3/18 failed to improve.

Discussion/Conclusion: The success rate and long-term duration is encouraging given the case severity. A control group would have been preferable, but each case could act as its own control, as conventional treatments had already failed. The only significant difference in the management of each case was the PAAG treatment. The method of action of PAAG is uncertain, and further work is required to study this.

Need expert advice?

Talk to the people in the know by contacting one of our Veterinary experts.
Contura Vet brings together the combined experience of bioengineering and veterinary expertise in the development of products for the treatment of osteoarthritis in animals.
Enquire now
General enquires
Email: Info@conturavet.com | Phone: +44 (0) 845 862 3292